{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:37Z","timestamp":1790820637539,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Research Council of Norway","award":["228200"],"award-info":[{"award-number":["228200"]}]},{"name":"India Nanomission","award":["DST\/IMRCD\/INNO-INDIGO\/NANOBREASTCO\/2015"],"award-info":[{"award-number":["DST\/IMRCD\/INNO-INDIGO\/NANOBREASTCO\/2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lipid nanocapsules (LNCs) are promising vehicles for drug delivery. However, since not much was known about cellular toxicity of these nanoparticles in themselves, we have here investigated the mechanisms involved in LNC-induced intoxication of the three breast cancer cell lines MCF-7, MDA-MD-231 and MDA-MB-468. The LNCs used were made of Labrafac\u2122 Lipophile WL1349, Lipoid<jats:sup>\u00ae<\/jats:sup>S75 and Solutol<jats:sup>\u00ae<\/jats:sup>HS15.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>High resolution SIM microscopy showed that the DiD-labeled LNCs ended up in lysosomes close to the membrane. Empty LNCs, i.e. without encapsulated drug, induced not only increased lysosomal pH, but also acidification of the cytosol and a rapid inhibition of protein synthesis. The cytotoxicity of the LNCs were measured for up to 72\u00a0h of incubation using the MTT assay and ATP measurements in all three cell lines, and revealed that MDA-MB-468 was the most sensitive cell line and MCF-7 the least sensitive cell line to these LNCs. The LNCs induced generation of reactive free oxygen species and lipid peroxidation. Experiments with knock-down of kinases in the near-haploid cell line HAP1 indicated that the kinase HRI is essential for the observed phosphorylation of eIF2\u03b1. Nrf2 and ATF4 seem to play a protective role against the LNCs in MDA-MB-231 cells, as knock-down of these factors sensitizes the cells to the LNCs. This is in contrast to MCF-7 cells where the knock-down of these factors had a minor effect on the toxicity of the LNCs. Inhibitors of ferroptosis provided a large protection against LNC toxicity in MDA-MB-231 cells, but not in MCF-7 cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High doses of LNCs showed a different degree of toxicity on the three cell lines studied, i.e. MCF-7, MDA-MD-231 and MDA-MB-468 and affected signaling factors and the cell fate differently in these cell lines.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12951-019-0567-y","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T06:02:31Z","timestamp":1578290551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Biological response and cytotoxicity induced by lipid nanocapsules"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2102-3741","authenticated-orcid":false,"given":"Marzena","family":"Szwed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-7194","authenticated-orcid":false,"given":"Maria Lyngaas","family":"Torgersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8064-4268","authenticated-orcid":false,"given":"Remya Valsala","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5749-1758","authenticated-orcid":false,"given":"Sunil Kumar","family":"Yadava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0178-2206","authenticated-orcid":false,"given":"Sascha","family":"Pust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-6117","authenticated-orcid":false,"given":"Tore Geir","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6524-612X","authenticated-orcid":false,"given":"Tore","family":"Skotland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-4912","authenticated-orcid":false,"given":"Jyotsnendu","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-9072","authenticated-orcid":false,"given":"Kirsten","family":"Sandvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"567_CR1","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387\u201392.","journal-title":"Cancer Res"},{"key":"567_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/10611869608996830","volume":"3","author":"A Gabizon","year":"1996","unstructured":"Gabizon A, Chemla M, Tzemach D, Horowitz AT, Goren D. Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. J Drug Target. 1996;3:391\u20138.","journal-title":"J Drug Target"},{"key":"567_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil(R)\u2013the first FDA-approved nano-drug: lessons learned. J Controll Release. 2012;160:117\u201334.","journal-title":"J Controll Release"},{"key":"567_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2018.11.029","volume":"293","author":"M Fusser","year":"2019","unstructured":"Fusser M, Overbye A, Pandya AD, Morch Y, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Maelandsmo GM. Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. J Controll Release. 2019;293:183\u201392.","journal-title":"J Controll Release"},{"key":"567_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1091\/mbc.E17-06-0419","volume":"29","author":"DS Redka","year":"2018","unstructured":"Redka DS, Gutschow M, Grinstein S, Canton J. Differential ability of proinflammatory and anti-inflammatory macrophages to perform macropinocytosis. Mol Biol Cell. 2018;29:53\u201365.","journal-title":"Mol Biol Cell"},{"key":"567_CR6","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1016\/j.celrep.2017.12.011","volume":"21","author":"DH Madsen","year":"2017","unstructured":"Madsen DH, Jurgensen HJ, Siersbaek MS, Kuczek DE, Grey Cloud L, Liu S, Behrendt N, Grontved L, Weigert R, Bugge TH. Tumor-associated macrophages derived from circulating inflammatory monocytes degrade collagen through cellular uptake. Cell Reports. 2017;21:3662\u201371.","journal-title":"Cell Reports."},{"key":"567_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrd4333","volume":"13","author":"VP Torchilin","year":"2014","unstructured":"Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Disc. 2014;13:813\u201327.","journal-title":"Nat Rev Drug Disc"},{"key":"567_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20\u201337.","journal-title":"Nat Rev Cancer"},{"key":"567_CR9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2217\/nnm.14.81","volume":"9","author":"T Skotland","year":"2014","unstructured":"Skotland T, Iversen TG, Sandvig K. Development of nanoparticles for clinical use. Nanomedicine (London, England). 2014;9:1295\u20139.","journal-title":"Nanomedicine (London, England)"},{"key":"567_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","volume":"26","author":"A Puri","year":"2009","unstructured":"Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26:523\u201380.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"567_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","volume":"379","author":"NT Huynh","year":"2009","unstructured":"Huynh NT, Passirani C, Saulnier P, Benoit JP. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379:201\u20139.","journal-title":"Int J Pharm"},{"key":"567_CR12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/biot.201100508","volume":"7","author":"T Murakami","year":"2012","unstructured":"Murakami T. Phospholipid nanodisc engineering for drug delivery systems. Biotechnol J. 2012;7:762\u20137.","journal-title":"Biotechnol J"},{"key":"567_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2017.09.031","volume":"266","author":"M Pitorre","year":"2017","unstructured":"Pitorre M, Gonde H, Haury C, Messous M, Poilane J, Boudaud D, Kanber E, Rossemond Ndombina GA, Benoit JP, Bastiat G. Recent advances in nanocarrier-loaded gels: which drug delivery technologies against which diseases? J Control Release. 2017;266:140\u201355.","journal-title":"J Control Release"},{"key":"567_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","volume":"12","author":"A Beloqui","year":"2016","unstructured":"Beloqui A, Solinis MA, Rodriguez-Gascon A, Almeida AJ, Preat V. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine. 2016;12:143\u201361.","journal-title":"Nanomedicine"},{"key":"567_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jconrel.2013.06.014","volume":"170","author":"G Bastiat","year":"2013","unstructured":"Bastiat G, Pritz CO, Roider C, Fouchet F, Lignieres E, Jesacher A, Glueckert R, Ritsch-Marte M, Schrott-Fischer A, Saulnier P, Benoit JP. A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. J Controll Release. 2013;170:334\u201342.","journal-title":"J Controll Release"},{"key":"567_CR16","doi-asserted-by":"publisher","first-page":"7542","DOI":"10.1016\/j.biomaterials.2010.06.024","volume":"31","author":"A Paillard","year":"2010","unstructured":"Paillard A, Hindre F, Vignes-Colombeix C, Benoit JP, Garcion E. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials. 2010;31:7542\u201354.","journal-title":"Biomaterials"},{"key":"567_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tiv.2017.03.007","volume":"41","author":"G Le Roux","year":"2017","unstructured":"Le Roux G, Moche H, Nieto A, Benoit JP, Nesslany F, Lagarce F. Cytotoxicity and genotoxicity of lipid nanocapsules. Toxicol In Vitro. 2017;41:189\u201399.","journal-title":"Toxicol In Vitro"},{"key":"567_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2889","volume":"13","author":"DL Holliday","year":"2011","unstructured":"Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. BCR. 2011;13:215.","journal-title":"BCR"},{"key":"567_CR19","first-page":"1","volume":"8","author":"M Szwed","year":"2019","unstructured":"Szwed M, Sonstevold T, Overbye A, Engedal N, Grallert B, Morch Y, Sulheim E, Iversen TG, Skotland T, Sandvig K, Torgersen ML. Small variations in nanoparticle structure dictate differential cellular stress responses and mode of cell death. Nanotoxicology. 2019;8:1\u201322.","journal-title":"Nanotoxicology."},{"key":"567_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1023\/A:1016121319668","volume":"19","author":"B Heurtault","year":"2002","unstructured":"Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19:875\u201380.","journal-title":"Pharm Res"},{"key":"567_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1242\/jcs.199240","volume":"130","author":"A Aulas","year":"2017","unstructured":"Aulas A, Fay MM, Lyons SM, Achorn CA, Kedersha N, Anderson P, Ivanov P. Stress\u2013specific differences in assembly and composition of stress granules and related foci. J Cell Sci. 2017;130:927\u201337.","journal-title":"J Cell Sci"},{"key":"567_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/tra.12468","volume":"18","author":"I Ailte","year":"2017","unstructured":"Ailte I, Lingelem AB, Kvalvaag AS, Kavaliauskiene S, Brech A, Koster G, Dommersnes PG, Bergan J, Skotland T, Sandvig K. Exogenous lysophospholipids with large head groups perturb clathrin-mediated endocytosis. Traffic (Copenhagen, Denmark). 2017;18:176\u201391.","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"567_CR23","doi-asserted-by":"crossref","first-page":"9681","DOI":"10.1016\/S0021-9258(17)44551-0","volume":"258","author":"A Ciechanover","year":"1983","unstructured":"Ciechanover A, Schwartz AL, Dautry-Varsat A, Lodish HF. Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem. 1983;258:9681\u20139.","journal-title":"J Biol Chem"},{"key":"567_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.nano.2015.02.010","volume":"11","author":"N Wauthoz","year":"2015","unstructured":"Wauthoz N, Bastiat G, Moysan E, Cieslak A, Kondo K, Zandecki M, Moal V, Rousselet MC, Hureaux J, Benoit JP. Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice. Nanomed Nanotechnol Biol Med. 2015;11:1237\u201345.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"567_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ceb.2016.01.006","volume":"39","author":"LA Huber","year":"2016","unstructured":"Huber LA, Teis D. Lysosomal signaling in control of degradation pathways. Curr Opin Cell Biol. 2016;39:8\u201314.","journal-title":"Curr Opin Cell Biol"},{"key":"567_CR26","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1016\/S0021-9258(17)34440-X","volume":"253","author":"F Cahn","year":"1978","unstructured":"Cahn F, Lubin M. Inhibition of elongation steps of protein synthesis at reduced potassium concentrations in reticulocytes and reticulocyte lysate. J Biol Chem. 1978;253:7798\u2013803.","journal-title":"J Biol Chem"},{"key":"567_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13:89\u2013102.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"567_CR28","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Rep. 2016;17:1374\u201395.","journal-title":"EMBO Rep"},{"key":"567_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.lfs.2017.08.003","volume":"186","author":"Y Cao","year":"2017","unstructured":"Cao Y, Long J, Liu L, He T, Jiang L, Zhao C, Li Z. A review of endoplasmic reticulum (ER) stress and nanoparticle (NP) exposure. Life Sci. 2017;186:33\u201342.","journal-title":"Life Sci"},{"key":"567_CR30","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1128\/MCB.21.23.7971-7980.2001","volume":"21","author":"L Lu","year":"2001","unstructured":"Lu L, Han AP, Chen JJ. Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol. 2001;21:7971\u201380.","journal-title":"Mol Cell Biol"},{"key":"567_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.redox.2017.02.018","volume":"12","author":"TA Theodossiou","year":"2017","unstructured":"Theodossiou TA, Olsen CE, Jonsson M, Kubin A, Hothersall JS, Berg K. The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy. Redox Biol. 2017;12:191\u20137.","journal-title":"Redox Biol"},{"key":"567_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165\u201376.","journal-title":"Trends Cell Biol"},{"key":"567_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka O, Shah R, Li B, FriedmannAngeli JP, Griesser M, Conrad M, Pratt DA. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3:232\u201343.","journal-title":"ACS Cent Sci."},{"key":"567_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.18-37","volume":"64","author":"S Kasai","year":"2019","unstructured":"Kasai S, Yamazaki H, Tanji K, Engler MJ, Matsumiya T, Itoh K. Role of the ISR-ATF4 pathway and its cross talk with Nrf2 in mitochondrial quality control. J Clin Biochem Nutr. 2019;64:1\u201312.","journal-title":"J Clin Biochem Nutr"},{"key":"567_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1085\/jgp.201110596","volume":"137","author":"JE DiCiccio","year":"2011","unstructured":"DiCiccio JE, Steinberg BE. Lysosomal pH and analysis of the counter ion pathways that support acidification. J Gen Physiol. 2011;137:385\u201390.","journal-title":"J Gen Physiol"},{"key":"567_CR36","first-page":"7","volume":"5","author":"R Marwaha","year":"2017","unstructured":"Marwaha R, Sharma M, DQ-Red BSA. Trafficking assay in cultured cells to assess cargo delivery to lysosomes. Bio Protoc. 2017;5:7.","journal-title":"Bio Protoc."},{"key":"567_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm3151","volume":"12","author":"HT McMahon","year":"2011","unstructured":"McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2011;12:517\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"567_CR38","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1038\/srep09004","volume":"5","author":"X Chen","year":"2015","unstructured":"Chen X, Bi Y, Wang T, Li P, Yan X, Hou S, Bammert CE, Ju J, Gibson KM, Pavan WJ, Bi L. Lysosomal targeting with stable and sensitive fluorescent probes (Superior LysoProbes): applications for lysosome labeling and tracking during apoptosis. Sci Rep. 2015;5:9004.","journal-title":"Sci Rep"},{"key":"567_CR39","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/ijms18112454","volume":"18","author":"E Sulheim","year":"2017","unstructured":"Sulheim E, Iversen TG, To Nakstad V, Klinkenberg G, Sletta H, Schmid R, Hatletveit AR, Wagbo AM, Sundan A, Skotland T, Sandvig K, Morch Y. Cytotoxicity of poly(alkyl cyanoacrylate) nanoparticles. Int J Mol Sci. 2017;18:2454.","journal-title":"Int J Mol Sci"},{"key":"567_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1083\/jcb.105.2.679","volume":"105","author":"K Sandvig","year":"1987","unstructured":"Sandvig K, Olsnes S, Petersen OW, van Deurs B. Acidification of the cytosol inhibits endocytosis from coated pits. J Cell Biol. 1987;105:679\u201389.","journal-title":"J Cell Biol"},{"key":"567_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2011.03.056","volume":"411","author":"C Maupas","year":"2011","unstructured":"Maupas C, Moulari B, Beduneau A, Lamprecht A, Pellequer Y. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells. Int J Pharm. 2011;411:136\u201341.","journal-title":"Int J Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0567-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-019-0567-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0567-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T05:06:44Z","timestamp":1613365604000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-019-0567-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s12951-019-0567-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}